Patient Registry Software Market to Cross US$ 4.4 Billion by 2032 | Says Future Market Insights,Incs.

The market for patient registry software is expected to reach US$ 4.4 billion by 2032, growing at a CAGR of 8.8% over that time. In 2022, the market will be worth US$ 1.9 billion. The market is expanding as a result of the healthcare industry’s growing adoption of EHRs. The market is anticipated to grow throughout the forecast period as a result of the implementation of numerous advantageous government initiatives.

For example, the U.S. introduced the Cures Act in 2016, which aims to create medical products and provide cutting-edge technologies in the medical industry. Additionally, it is projected that the integration of AI into EHRs would present a number of growth prospects.

For instance, in October 2019, North well Health and several scripts reached a deal to provide the next-generation electronic. The agreement aims to massive revenue generation, thereby, fuelling the market expansion in the coming time.

Request Sample Report @
https://www.futuremarketinsights.com/reports/sample/rep-gb-14633

The expansion of the market, however, is anticipated to be constrained in the projected term by worries about data security and privacy. The Identity Theft Resource Centre reports that there were approximately 1.473 breaches in the United States in 2019, up 17% from the previous year. The emergence of cloud-based EHR is predicted to present the market with considerable prospects and serve as a significant counter to the obstructing factor, consequently promoting market growth.

Key Takeaways from the Market Study

• The global patient registry market is expected to garner US$ 1.9 Billion in 2022
• Global market demand flourished at a 10.4% CAGR from 2015 to 2021
• The commercial registry software segment to expand at 8.9% from 2022 to 2032
• The US market size to garner US$ 1.5 Billion by 2032
• Market in Brazil to value US$ 57 Million from 2022- to 2032
• The CAGR of China is expected to be 10.5% from 2022 to 2032
• The diabetes registry segment is projected to experience a CAGR of 9.3% from 2022 to 2032

Competition Analysis 

Key players in the global patient registry software market include Dacima Software Inc., Evado eClinical Solutions, IQVIA, Global Vision Technologies Inc., and Invitae. Recent developments among key players are:

• In June 2020, ArborMetrix Inc. (US) entered into a strategic partnership with The Society of Interventional Radiology (SIR). The initiative aims to offer the IR Quality Registry to enhance patient care by deploying analytics.
• In March 2021, ESO Solutions announced a strategic partnership with Virginia EMS Systems (US) to provide an EMS data repository and trauma registry across the state.
• In April 2021, IQVIA Holdings accomplished the remaining 40% of Q2 solutions from diagnostic information services providers Quest Diagnostics.
• In December 2020, ImageTrend, Inc. (US) disclosed the latest National Trauma Data Bank (NTDB) Data Dictionary that would be available in the Patient Registry from January 1, 2021.

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global patient registry software market, presenting a historical analysis from 2015 to 2021 and forecast statistics for the period of 2022-2032.

Key Segments Covered in the Patient Registry Software Market Report

By Type:

• Public Domain
• Commercial

By Disease Area:

• Diabetes
• Cardiovascular
• Cancer Patient
• Rare Disease/Orphan Disease
• Other Chronic Disease

By End User:

• Governments
• Commercial Use

By Region:

• North America
• Europe Patient
• Asia Pacific
• MEA Patient
• Latin America